CYTOMEGALOVIRUS (CMV)-SPECIFIC T-CELL IMMUNE RECONSTITUTION IN HEMATOPOIETIC CELL TRANSPLANT (HCT) RECIPIENTS FOLLOWING LETERMOVIR PROPHYLAXIS USING T-SPOT.CMV

BONE MARROW TRANSPLANTATION(2023)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要